DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Lukacs B, McCarthy C, Grange JC.
Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice.
Eur Urol 1993;
24 (Suppl. 01) 34-40
Access:
We do not assume any responsibility for the contents of the web pages of other providers.